Re-evaluating Selective Screening Criteria for Chlamydial Infection among Women in the U.S. Pacific Northwest

Sexually Transmitted Diseases

Volumn 31, Issue 5, 2004, Pages 283-289

  La Montagne, D Scott ^a,b   Patrick, L Elizabeth ^b   Fine, David N ^b   Marrazzo, Jeanne M ^c  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b Center for Health Training   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ANAMNESIS; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; EVALUATION; FEMALE; HEALTH PROGRAM; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MEDICAL RECORD; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PERFORMANCE; PREDICTION; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SENSITIVITY AND SPECIFICITY; UNITED STATES; UTERINE CERVICITIS;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MASS SCREENING; MEDICAL RECORDS; NORTHWESTERN UNITED STATES; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SELECTION; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 2142639391     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.OLQ.0000124613.85111.6B     Document Type: Article

References (44)

1. Department of Health and Human Services. Sexually transmitted disease surveillance 2000. Atlanta: Division of STD Prevention, Center for Disease Control and Prevention, 2001.
2. McCormack WM, Alpert S, McComb DE, et al. Fifteen-month follow-up study of women infected with Chlamydia trachomatis. N Engl J Med 1979; 300:123-125.
3. Schachter J, Stoner E, Moncada J. Screening for chlamydial infections in women attending family planning clinics. West J Med 1983; 138:375-379.
4. Brunham RC, Paavonen J, Stevens CE, et al. Mucopurulent cervicitis - The ignored counterpart in women of urethritis in men. N Engl J Med 1984; 311:1-6.
5. Westrom L, Joesoef R, Reynolds G, et al. Pelvic inflammatory disease and fertility. A cohort study of 1844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992; 19:185-192.
6. Hillis SD, Owens LM, Marchbanks PA, et al. Recurrent chlamydial infections increase the risk of hospitalization for ectopic pregnancy and pelvic inflammatory disease. Am J Obstet Gynecol 1997; 1:103-106.
7. Cates W Jr, Wasserheit JN. Genital chlamydial infections: Epidemiology and reproductive sequelae. Am J Obstet Gynecol 1991; 164:1771-1781.
8. DeMuylder X, Laga M, Tennstedt C, et al. The role of Neisseria gonorrhoeae and Chlamydia trachomatis in pelvic inflammatory disease and its sequelae in Zimbabwe. J Infect Dis 1990; 162:501-505.
9. Miettinen A, Heinonen PK, Teisala K, et al. Serologic evidence for the role of Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma hominis in the etiology of tubal factor infertility and ectopic pregnancy. Sex Transm Dis 1990; 17:10-14.
10. Mabey DCW, Ogbaselassie G, Robertson JN, et al. Tubal infertility in the Gambia: Chlamydial and gonococcal serology in women with tubal occlusion compared with pregnant controls. Bull World Health Organ 1985; 63:1107-1113.
11. Tjiam KH, Zeilmaker GH, Alberda AT, et al. Prevalence of antibodies to Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma hominis in infertile women. Genitourin Med 1985; 61:175-178.
12. Robertson JN, Ward ME, Conway D, et al. Chlamydial and gonococcal antibodies in sera of infertile women with tubal obstruction. J Clin Pathol 1987; 40:377-383.
13. Ness RB, Goodman MT, Shen C, et al. Serologic evidence of past infection with Chlamydia trachomatis, in relation to ovarian cancer. J Infect Dis 2003; 187:1147-1152.
14. Lossick J, DeLisle S, Fine D, et al. Regional program for widespread screening for Chlamydia trachomatis in family planning clinics. In: Bowie WR, Caldwell HD, Jones RP, et al., eds. Chlamydial Infections: Proceedings of the Seventh International Symposium on Human Chlamydial Infections. Cambridge: Cambridge University Press, 1990:575-579.
15. Britton TF, Delisle S, Fine D. STDs and family planning clinics: A regional program for chlamydia control that works. Am J Gynecol Health 1992; 6:80-87.
16. Region X Infertility Prevention Project Manual. Seattle: Center for Health Training, 2002.
17. Handsfield HH, Jasman LL, Roberts PL, et al. Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics. JAMA 1986; 255:1730-1734.
18. Marrazzo JM, Celum CL, Hillis SD, et al. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women: Implications for a national chlamydia control strategy. Sex Transm Dis 1997; 24:131-141.
19. Marrazzo JM, Fine D, Celum CL, et al. Selective screening for chlamydial infection in women: A comparison of three sets of criteria. Fam Plann Perspect 1997; 29:158-162.
20. Han Y, Coles FB, Hipp S. Screening criteria for Chlamydia trachomatis in family planning clinics: Accounting for prevalence and clients' characteristics. Fam Plann Perspect 1997; 29:163-166.
21. Stamm WE. Chlamydia trachomatis infections of the adult. In: Holmes KK, Sparling PF, Mardh PA, et al., eds. Sexually Transmitted Diseases, 3rd ed. McGraw-Hill Health Professions Division, 1999:407-422.
22. Mertz KJ, Levine WC, Mosure DJ, et al. Trends in the prevalence of chlamydial infections - The impact of community-wide testing. Sex Transm Dis 1997; 24:169-175.
23. Herrmann B, Egger M. Genital Chlamydia trachomatis infections in Uppsala County, Sweden, 1985-1993: Declining rates for how much longer? Sex Transm Dis 1995; 22:253-260.
24. Kretzschmar M, Welte R, van den Hoek A, et al. Comparative model-based analysis of screening programs for Chlamydia trachomatis infections. Am J Epidemiol 2001; 153:90-101.
25. Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infections. N Engl J Med 1996; 334:1362-1366.
26. Ostergaard L, Andersen B, Moeller JK, et al. Home sampling versus conventional swab samples for screening of Chlamydia trachomatis in women: A cluster-randomized 1-year follow-up study. Clin Infect Dis 2000; 31:951-957.
27. Howell MR, Quinn TC, Brathwaite W, et al. Screening women for Chlamydia trachomatis in family planning clinics - The cost-effectiveness of DNA amplification assays. Sex Transm Dis 1998; 25:108-117.
28. Townsend JRP, Turner HS. Analysing the effectiveness of chlamydia screening. J Oper Res Soc 2000; 51:812-824.
29. Welte R, Kretzschmar M, Leidl R, et al. Cost-effectiveness of screening programs for Chlamydia trachomatis - A population-based dynamic approach. Sex Transm Dis 2000; 27:518-529.
30. Honey E, Augood C, Templeton A, et al. Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies. Sex Transm Infect 2002; 78:406-412.
31. Dicker LW, Mosure DJ, Levine WC, et al. Impact of switching laboratory tests on reported trends in Chlamydia trachomatis infections. Am J Epidemiol 2000; 151:430-435.
32. Department of Health and Human Services. Chlamydia prevalence monitoring project annual report-2001. Atlanta: Division of STD Prevention, Centers for Disease Control and Prevention, 2002.
33. Gotz H, Lindback J, Ripa T, et al. Is the increase in notifications of Chlamydia trachomatis infections in Sweden the result of changes in prevalence, sampling frequency, or diagnostic methods? Scand J Infect Dis 2002; 34:28-34.
34. Mosure DJ, Berman S, Dicker LW, et al. A re-evaluation of selective screening criteria for women attending family planning clinics in the US. In: Stephens RS, et al., eds. Chlamydial Infections: Proceedings of the Ninth International Symposium on Human Chlamydial Infection. San Francisco: International Chlamydia Symposium, 1998:333-336.
35. Miller WC, Hoffman IF, Owen-O'Dowd J, et al. Selective screening for chlamydial infection: Which criteria to use? Am J Prev Med 2000; 18:115-122.
36. United States Preventive Services Task Force. Screening for chlamydial infection: Recommendations and rationale. Am J Prev Med 2001; 20:90-94.
37. Fenton KA, Korovessis C, Johnson AM, et al. Sexual behaviour in Britain: Reported sexually transmitted infections and prevalence genital Chlamydia trachomatis seroprevalence. Lancet 2001; 358:1851-1854.
38. Grun L, Tassano-Smith J, Carder C, et al. Comparison of two methods of screening for genital chlamydial infection in women attending general practice: Cross sectional survey. BMJ 1997; 315:226-230.
39. Gaydos C, Howell R, Pare B, et al. Chlamydia trachomatis infections in female military recruits. N Engl J Med 1998; 339:739-744.
40. Hiltunen-Back E, Haikala O, Kautiainen H, et al. A nationwide sentinel clinic survey of Chlamydia trachomatis infection in Finland. Sex Transm Dis 2001; 28:252-258.
41. Todd CS, Haase C, Stoner BP. Emergency department screening for asymptomatic sexually transmitted infections. Am J Public Health 2001; 91:461-464.
42. Penney G, Thomson M, Norman J, et al. A randomized comparison of strategies for reducing infective complications of induced abortions. Br J Obstet Gynaecol 1998; 105:599-604.
43. Ryan G, Abdella T, McNeeley G, et al. Chlamydia trachomatis infection in pregnancy and effect of treatment on outcome. Am J Obstet Gynecol 1990; 162:34-39.
44. Black CM, Marrazzo J, Johnson RE, et al. Head-to-heat multicenter comparison of DNA probe and nucleic acid amplification tests for Chlamydia trachomatis infection in women performed with an improved reference standard. J Clin Microbiol 2002; 40:3757-3763.